Drugs I Flashcards
3 agonists for gastric acid production
H, AcH, and gastrin
- tidine drugs
- clinical uses (3)
- pronounced effect on…
- adverse
H2 receptor complete antagonists (only H2 no H1 or H3)
2nd line GERD and most PUD, as effective as PPI for NSAID incued ulcers, OTC preps for dyspepsia
nocturnal acid secretion (H2 dependent)
-crosses placenta/breast milk
Cimetidine
Potency/SFX
H2 receptor competitive antagonists (only H2 no H1 or H3)
Weakest potency
slows hepatic metabolism
Ranitidine
Potency/SFX
H2 receptor complete antagonists (only H2 no H1 or H3)
Medium potency
slows hepatic metabolism less than cimetidine
Nazitidine
Potency/SFX
H2 receptor complete antagonists (only H2 no H1 or H3)
Medium potency
Fanotidine
Potency/SFX
H2 receptor complete antagonists (only H2 no H1 or H3)
Strongest potency
Best trx for frequent GERD
H2 antagonist 2x daily with PPI
- prazoles
- mechanism
- when do they work
Bioavailability
T1/2
Irreversible Proton Pump inhibitors
Prodrugs
suppress fasting and meal acid stimulation=98% acid decrease
Decreased 50% by food-take before
2 hours but irreversible antagonist so works longer
-prazoles vs -tidines
better for PUD-heal ulcers faster (esp duo)
- prazoles
- clincal uses
first line GERD and PUD-including H. pylori (triple therapy) and NSAID ulcers
Triple therapy components
Quad therapy components
H2 antagonist, PPI, metronidazole,/clarithomyocin
- prazoles SFX
- 1 special and important association
Increase gastric bacterial contents>enteric infection
-worried about C. dif in hospital
when to take -tidines vs -prazoles
both before eating (1 hour ideally)
CaCO3, Mg (Oh2)+Al (OH3), Mg(OH)2+CaCO3
antacids
Antacids
- mechanism
- clinical use
- SFX
Weak bases that react with HCl to reduce gastric acid/peptic activity (pepsin inactivated at pH>4)
primary trx for intermittent heart burn
Bloating depending on base
Dementia causing drugs
Bismuth compounds and -prazoles in 75+ yo
Sucralfate
- Reaction
- mechanism (2)
- effects (2)
- Clinical Use
- SFX
- Contraindication
Octasulfate+Al(OH)3
Selectively binds and coats necrotic ulcer but requires Acidic conditions in gut to be activated
Acts as barrier to acid, pepsin, and bile
Stimulates synthesis of PGE-stim mucos and HCO3 secretion
Preventing and healing duodenal ulcers
Constipation 2%
Should not be taken with H2 antagonists/PPI/antacids-need acidic environment to work
Colloidal Bismuth compounds
- mech
- effects 92)
- CLinical use
- SFX
- selectively bind and coat necrotic ulcer
- acts as barrier to acid/pepsin+direct antimicrobial activity vs H. pylori+binds ENTEROTOXINS
- trx H. pylori ulcers when combined with Abx (2nd line)
Risk of enteric infection-supressed gastric acid barrier
Misoprostol
- mech
- effects (3)
- CLincal Use
- SFX (2)
PGE1 analog
mucosal protective effects via stim of mucus and HCO3 production+increase BF+reduces H2 induced cAMP production (less acid secretion)
Prevention of NSAID induced ulcers
Dose dependent D+Stimulant effect on uterus (don’t give to childbearing-age women)
Metoclopramide
- mech
- effects (4)
- clincal use and primary use
- SFX (4)
D2-R antagnoist
hasten eso clearance, raises LES, and accelerates gastric emptying+antiemtic properties
Gastric motor failure (post Surgery or DM)
Primarily Antiemetic agent
Extrapyramidal Sx (Parkinsonism/Tardive dyskinesia), anxiety, depression, drowsiness
Lubiprostone
- mech
- effects (3)
- clincal use (2)
- SFX
- Contraindication
FA drives form PGE1 that activates type 2 Cl channel
Produces Cl rich fluid that softens stool, cinreases motility, and promotes spontaneous BM
Chornic idiopathic constipation and IBS with C
D
Children